Judun Zheng

Dr. Judun Zheng

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2023 in Advanced Materials
Verified
Journal Article
Closed access
HGHaitao Guan
Haitao Guan
WWWei Wang
Wei Wang
ZJZichao Jiang
Zichao Jiang
BZBoyu Zhang
Boyu Zhang
ZYZhipeng Ye
Zhipeng Ye
YZYingze Zhang
Yingze Zhang

15 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZLZeyu Liu
Zeyu Liu
MLMinying Li
Minying Li
QXQiulin Xie
Qiulin Xie
YLYinghui Liu
Yinghui Liu
JHJialin Huang
Jialin Huang
YLYuhui Liao
Yuhui Liao
Fungal biofilms, as self-produced extracellular polymeric substances that resist antifungal agents and immune defense, represent a major cause of treatment failure and recurrent infections. Therefore, it is of great importance to eradicate fungal biofilms to achieve efficient therapy. This study develops a synergistic reactive oxygen species (ROS)-enhanced strategy to eradicate Candida albicans biofilms by designing ultrasound-light dual-responsive nanohybrids (UCNP@CR). The system integrates thulium-doped upconversion nanoparticles (UCNPs) with carbon nitride-coated surfaces (g-C3N4) and polypyridine ruthenium complex (Ru) photosensitizers. In treatment, the dense fungal biofilm can be effectively loosened under ultrasound stimulation while ultrasound simultaneously triggers ROS production of UCNP@CR, collectively promoting irreversible destruction of biofilm and inward penetration of photosensitizer. Moreover, UCNP@CR exhibits strong fungal adhesion, while its g-C3N4-mediated enhanced metal-to-ligand charge transfer (MLCT) process of Ru under near-infrared light irradiation amplifies ROS generation, which leads to efficient eradication of fungal biofilms. As in vivo experimental evidence, UCNP@CR exhibits excellent antifungal efficacy in treating fungal biofilm-infected wounds in immunosuppressed male mice under ultrasound-light stimulation. These findings establish the ultrasound-assisted, ROS-enhanced synergistic strategy as a promising approach against fungal biofilm infections and provide diverse perspective for managing other biofilm-related infectious diseases.

12 December 2025 in Science Advances
Verified
Journal Article
Open access
CZChengli Zhang
Chengli Zhang
XGXiaolong Guo
Xiaolong Guo
JZJudun Zheng
Judun Zheng
YFYi Feng
Yi Feng
WWWenjie Wu
Wenjie Wu
YLYuhui Liao
Yuhui Liao
Rapid detection of multibacterial pathogens is crucial for accelerating the diagnosis and treatment of bacterial infections. We propose a rapid and efficient electrochemiluminescence (ECL) sensor for the synchronous detection of multiple bacterial pathogens, including Staphylococcus aureus , Klebsiella pneumoniae , Pseudomonas aeruginosa , and methicillin-resistant S. aureus . This homogeneous sensor is based on a self-assembled DNA nanosphere loaded with tetrakis (4-carboxyphenyl) porphyrin (TCPP). The sensor operates in an “off-on” mode, in which bacterium-aptamer binding triggers a conformational change in the DNA nanosphere, releasing TCPP and generating an enhanced ECL signal. The inclusion of cerium nanoparticles boosts signal intensity through electrocatalytic reactions, improving sensitivity with a detection limit of ≤100 colony-forming units per milliliter. Integrated with a microfluidic chip, the system enables multibacterial detection in just 45 minutes. Bacterial quantification in clinical samples strongly correlates with digital polymerase chain reaction results. This approach provides a rapid, specific, and efficient diagnostic tool for bacterial infections with great potential for point-of-care applications in clinical settings.

8 November 2024 in Advanced Science
Verified
Journal Article
Open access
WLWeiqiang Lin
Weiqiang Lin
CSChenguang Shen
Chenguang Shen
MLMengjun Li
Mengjun Li
SMShengchao Ma
Shengchao Ma
CLChenxin Liu
Chenxin Liu
YLYuhui Liao
Yuhui Liao
The emergence of monkeypox has become a global health threat after the COVID‐19 pandemic. Due to the lack of available specifically treatment against MPV, developing an available vaccine is thus the most prospective and urgent strategy. Herein, a programmable macrophage vesicle based bionic self‐adjuvanting vaccine (AM@AEvs‐PB) is first developed for defending against monkeypox virus (MPV). Based on MPV‐related antigen‐stimulated macrophage‐derived vesicles, the nanovaccine is constructed by loading the mature virion (MV)‐related intracellular protein (A29L/M1R) and simultaneously modifying with the enveloped virion (EV) antigen (B6R), enabling them to effectively promote antigen presentation and enhance adaptive immune through self‐adjuvant strategy. Owing to the synergistic properties of bionic vaccine coloaded MV and EV protein in defensing MPV, the activation ratio of antigen‐presenting cells is nearly four times than that of single antigen in the same dose, resulting in stronger immunity in host. Notably, intramuscular injection uptake of AM@AEvs‐PB demonstrated vigorous immune‐protective effects in the mouse challenge attempt, offering a promising strategy for pre‐clinical monkeypox vaccine development.

25 April 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
WLWeiqiang Lin
Weiqiang Lin
JHJialin Huang
Jialin Huang
SGShuang Guo
Shuang Guo
MZMeijiao Zhao
Meijiao Zhao
XCXu Chen
Xu Chen
YLYuhui Liao
Yuhui Liao
A tunable fluorescent probe for superoxide anion detection during inflammation caused byTreponema pallidum.

10 January 2025 in Chemical Engineering Journal
Verified
Journal Article
Closed access
QZQin Zeng
Qin Zeng
YZYing Zhang
Ying Zhang
JZJudun Zheng
Judun Zheng
JLJingyan Lin
Jingyan Lin
NLNing Li
Ning Li
YLYuhui Liao
Yuhui Liao